Investors have a wide selection of ASX bank shares to choose from, including ANZ Group Holdings Ltd (ASX: ANZ) shares. To decide which is a good option, we should look at what the potential returns could be.

While there are similarities to National Australia Bank Ltd (ASX: NAB), Commonwealth Bank of Australia (ASX: CBA) and Westpac Banking Corp (ASX: WBC), there are differences in terms of how much earnings comes from lending to households, business banking services and so on.

Let’s look at the predicted returns from analysts regarding ASX shares.

ANZ share price target

A price target tells investors where they think the share price will be in 12 months from the time of the investment call.

Obviously, a price target is not a guaranteed return (or decline), but it does indicate whether they think the business is overvalued or undervalued.

According to CMC Invest, there have been eight ratings on the business within the last three months, with three of those being a buy, four being a hold and one being a sell.

Of those eight ratings, the average price target is $35.66, which implies a possible decline of 6% over the next year.

The latest update from the ASX bank share was the third-quarter of FY26. Compared to the quarterly average of the first half of FY26, operating income grew 1%, operating expenses increased 2%, leading to profit before provisions being flat, and cash profit increased 1% to $1.9 billion.

A growth rate of 1% for cash profit is not exactly going to excite the market.

However, its loan growth was slightly faster, with net loans and advances increasing by 3% between March 2026 and June 2026, reaching $846 billion. Meanwhile, customer deposits rose 2% over the three months, with the balance reaching $786 billion at 30 June 2026.

With a $10,000 investment in ANZ shares, a decline of 6% would become approximately $9,400.

Potential dividends?

ASX bank shares like ANZ are known for their dividends, and the passive income is normally a sizeable amount.

According to CMC Invest, the business is projected to pay an amount that equates to a dividend yield of 4.5% excluding franking credits and approximately 5.9% with franking credits.

Therefore, the passive income may offset the potential capital decline, bringing the total investment return to around $10,000.

However, I’m not sure that investing for a flat return is an appealing option. If I were going to invest in an ASX share, I’d rather pick something I was more confident about the prospects for positive returns.

The post By September 2027, ANZ shares could turn $10,000 into… appeared first on The Motley Fool Australia.

More reading

• How much superannuation do I need to retire with a $50,000 annual passive income?
• ASX 200 bank shares led a financial sector rebound last week
• What’s driving the ASX 200 higher today?
• Australia’s economy just grew faster than expected. What does this mean for ASX shares?
• How Westpac, ANZ, NAB and CBA shares stacked up in August

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

After racing higher for much of 2026, BHP Group Ltd (ASX: BHP) has given back some ground.

The mining giant finished Friday at $62.25, down 2.4% for the session and 7.5% over the past week.

That leaves the stock nearly 10% below the $68.77 high it reached on 26 August.

Even after the recent weakness, BHP shares are still up around 37% in 2026 and almost 50% over the past 12 months.

So, after a quick pullback, is this a better time to buy?

What’s behind the pullback?

Some of last week’s weakness came from BHP trading ex-dividend on last Thursday.

The miner declared a final dividend of 99 US cents per share after its FY26 result, with payment due on 23 September. The shares fell 3.28% on Wednesday, another 1.35% on Thursday and 2.4% on Friday.

There is also a bit happening around BHP’s Western Australian iron ore business.

According to The Australian, China’s Baowu Steel Group has been linked with buying a 15% to 25% stake in the Jimblebar iron ore mine.

BHP has not confirmed anything, although it did leave the door open. The company said it has “a long history of partnerships at its assets” and regularly looks at options that could create long-term value for shareholders.

The reports have also caught the attention of politicians, with some raising concerns about a Chinese state-owned group taking a stake in one of Australia’s major iron ore assets.

The business still looks strong

The recent pullback in the share price doesn’t really change what I like about BHP.

The company still delivered a strong FY26 result, with underlying EBITDA of around US$33 billion and attributable profit of US$9.8 billion.

What interests me most is the growing contribution from copper. It made up more than half of underlying EBITDA for the first time, which is a pretty big shift in the earnings mix.

BHP is already one of the world’s largest copper producers, and management expects its project pipeline to lift production by around 40% by FY35.

This gives BHP more exposure to copper, which should benefit from growing investment in electrification, power grids and data centres.

Would I buy BHP shares?

This is where I would be a little careful.

The business is performing well, but the share price has already had a huge run and brokers aren’t exactly calling it cheap.

TipRanks shows an average 12-month price target of $59.17, around 5% below Friday’s close. Of the 15 recent ratings shown, 13 are holds, with one buy and one sell.

Morgan Stanley is more bullish, with a buy rating and $68 price target. Even so, that would only put the shares around 9% above their current level.

I like BHP as a long-term exposure to copper, but after a 37% rise this year, I’d prefer to wait for a slightly better entry point before buying.

The post This ASX 200 giant is up 37% in 2026. Is the pullback worth buying? appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Pro Medicus, BHP, CBA shares
• No savings at 30? Here’s how I’d aim to retire early with $1 million buying ASX shares
• What’s driving the ASX 200 higher today?
• 11 ASX 200 shares with reaffirmed buy ratings post-results
• Top 3 ASX 200 shares that lifted their dividend this reporting season

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BHP Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares fell 0.95% last week and are up 2% over 12 months.

Let’s start the new week with some fresh ratings from the experts (courtesy The Bull). 

Pro Medicus Ltd (ASX: PME)

The Pro Medicus share price fell 4.15% to $173.95 last week.

Pro Medicus shares have been killing it over the past six months — up 32%.

Stuart Bromley from Medallion Financial Group has a buy rating on this ASX 200 healthcare share.

Bromley commented:

Pro Medicus is a global leader in medical imaging software, with its Visage platform increasingly adopted by major US hospital networks.

Revenue of $261.7 million in full year 2026 rose 22.9 per cent on the prior corresponding period. Underlying net profit after tax of $144.7 million was up 24.1 per cent.

Revenue and underlying net profit exceeded expectations, while the underlying earnings before interest and tax margin reached an exceptional 74.9 per cent. It signed 10 new contacts worth $407 million in full year 2026. It renewed six contracts on five year terms to the value of $141 million.

Recent share price weakness provides an attractive entry point into a high quality growth businesses.

BHP Group Ltd (ASX: BHP)

The BHP share price fell 7.5% last week to $62.25, well off its new record of $68.77 set last month.

Blake Halligan from Gray Perry Wealth Advisers has a hold rating on the market’s largest ASX 200 mining share. 

Halligan said:

BHP remains a high quality diversified miner with large, low cost assets and increasing exposure to copper.

The company’s fiscal year 2026 result was strong, with it generating attributable profit of $US9.8 billion, up 9 per cent on the prior corresponding period. Revenue of $US58.8 billion was up 15 per cent.

Rising copper demand from electrification and data centres support the longer term outlook, while iron ore operations remain highly competitive.

Commodity-price sensitivity and project execution risks support retaining BHP rather than increasing exposure.

Commonwealth Bank of Australia (ASX: CBA)

The CBA share price rose 2.02% last week to $160.42 amid a financial sector rally due to better-than-expected GDP data.

Bromley has a sell rating on this ASX 200 bank share. 

He explained:

CBA remains Australia’s highest quality major bank. The company posted cash net profit after tax of $10.982 billion in full year 2026, up 7 per cent on the prior corresponding period. The full year dividend of $5.05, fully franked, is up 4 per cent.

Despite the strong result, we believe the valuation is stretched, particularly as higher interest rates weigh on housing activity and credit growth. 

CBA shares were recently trading at historically elevated valuations compared to global peers. Better valuation opportunities exist elsewhere.

The recent dividend yield of 3.16 per cent lacks appeal.

The post Buy, hold, sell: Pro Medicus, BHP, CBA shares appeared first on The Motley Fool Australia.

More reading

• Experts name 3 top ASX shares to buy this week
• What Warren Buffett’s investing style can teach superannuation investors
• This ASX 200 giant is up 37% in 2026. Is the pullback worth buying?
• These ASX 50 shares have lost up to 60%. Is the sell-off overdone?
• 5 things to watch on the ASX 200 on Monday

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended BHP Group and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.